UCSF at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
UCSF brings 33 presentations to ASH 2026 in New Orleans. Its program centres on CAR T-cell therapy and bispecific antibodies in myeloma and lymphoma. It covers droplet PCR for tracking residual leukemia and cell-free DNA for lymphoma diagnosis in sub-Saharan Africa.
| Organization | ASH 2026 Attendance |
|---|---|
UCSF San Francisco, CA | |
University of California's health sciences campus in San Francisco, focused on medicine, biomedical research and graduate health education. | Talk Fri Dec 11 9:00am–12:00pm Symposium Fri Dec 11 11:00am–2:00pm A Case-Based Exploration of CAR T-Cell Therapy in Multiple Myeloma – Where We Are, Where We’re Going Real patient cases showing how experts use approved and investigational CAR-T therapies in multiple myeloma now, and where the treatment is heading. Symposium Fri Dec 11 3:00pm–6:00pm Medical Crossfire®: Strategic Sequencing in ALL — From Asparaginase to Cellular Therapy in an MRD-Driven Era Ordering acute lymphoblastic leukemia therapies, from asparaginase to bispecifics and CAR-T, guided by sensitive residual disease testing. Symposium Fri Dec 11 7:00pm–10:00pm Advancing the DLBCL Paradigm: Sequencing Bispecifics in Optimizing Patient Care Where bispecific antibodies fit in diffuse large B-cell lymphoma, weighed against CAR-T by patient fitness, access, and T-cell health. Oral Sat Dec 12 9:30am–11:00am Oral Sat Dec 12 9:30am–11:00am Oral Sat Dec 12 4:00pm–5:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Talk Sat Dec 12 6:00pm–8:00pm Talk Sat Dec 12 6:00pm–8:00pm Talk Sun Dec 13 8:00am–9:00am Talk Sun Dec 13 9:30am–10:45am Promoting the Peacekeepers: Treg Adoptive Therapies to Re-Establish Tolerance Regulatory T cells redirected with chimeric antigen receptors to restore immune tolerance in rheumatoid arthritis, from lab studies to clinical findings. Oral Sun Dec 13 9:30am–11:00am Oral Sun Dec 13 9:30am–11:00am Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Talk Mon Dec 14 2:45pm–4:15pm Talk Mon Dec 14 4:30pm–5:45pm Bispecific Antibodies OR CAR-T in Early Relapse for Multiple Myeloma Comparing CAR-T cells with off-the-shelf bispecific antibodies for early-relapse myeloma, weighing trial evidence, risks, and the best treatment order. Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at UCSF
Tell us what you sell and we’ll find the people at UCSF most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction